These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 28836585
1. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients. Yu ZC, Zhou PJ, Wang XH, Françoise B, Xu D, Zhang WX, Chen B. Acta Pharmacol Sin; 2017 Nov; 38(11):1566-1579. PubMed ID: 28836585 [Abstract] [Full Text] [Related]
2. Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients. de Winter BC, van Gelder T, Glander P, Cattaneo D, Tedesco-Silva H, Neumann I, Hilbrands L, van Hest RM, Pescovitz MD, Budde K, Mathot RA. Clin Pharmacokinet; 2008 Nov; 47(12):827-38. PubMed ID: 19026038 [Abstract] [Full Text] [Related]
3. Population pharmacokinetics of mycophenolic acid in renal transplant recipients. van Hest RM, van Gelder T, Vulto AG, Mathot RA. Clin Pharmacokinet; 2005 Nov; 44(10):1083-96. PubMed ID: 16176120 [Abstract] [Full Text] [Related]
8. Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Chinese Renal Allograft Recipients After Administration of EC-MPS. Chen B, Shao K, An HM, Shi HQ, Lu JQ, Zhai XH, Liu XX, Wang XH, Xu D, Zhou PJ. J Clin Pharmacol; 2019 Apr 01; 59(4):578-589. PubMed ID: 30537048 [Abstract] [Full Text] [Related]
10. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease. de Winter BC, Mathot RA, Sombogaard F, Neumann I, van Hest RM, Doorduijn JK, van Gelder T. Ther Drug Monit; 2010 Oct 01; 32(5):606-14. PubMed ID: 20720518 [Abstract] [Full Text] [Related]
11. Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients. Punyawudho B, Lertdumrongluk P, Somparn P, Kittanamongkolchai W, Traitanon O, Avihingsanon Y, Vadcharavivad S. Int J Clin Pharmacol Ther; 2012 Apr 01; 50(4):272-80. PubMed ID: 22456298 [Abstract] [Full Text] [Related]
12. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children. Barau C, Furlan V, Debray D, Taburet AM, Barrail-Tran A. Br J Clin Pharmacol; 2012 Sep 01; 74(3):515-24. PubMed ID: 22329639 [Abstract] [Full Text] [Related]
13. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis. Yang CL, Sheng CC, Liao GY, Su Y, Feng LJ, Xia Q, Jiao Z, Xu DJ. J Clin Pharm Ther; 2021 Dec 01; 46(6):1564-1575. PubMed ID: 34312870 [Abstract] [Full Text] [Related]
14. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome. Zhao W, Elie V, Baudouin V, Bensman A, André JL, Brochard K, Broux F, Cailliez M, Loirat C, Jacqz-Aigrain E. Br J Clin Pharmacol; 2010 Apr 01; 69(4):358-66. PubMed ID: 20406220 [Abstract] [Full Text] [Related]
16. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil. Ling J, Shi J, Jiang Q, Jiao Z. Eur J Clin Pharmacol; 2015 Jan 01; 71(1):95-106. PubMed ID: 25327506 [Abstract] [Full Text] [Related]
18. C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation. Baldelli S, Merlini S, Perico N, Nicastri A, Cortinovis M, Gotti E, Remuzzi G, Cattaneo D. Pharmacogenomics; 2007 Sep 01; 8(9):1127-41. PubMed ID: 17924828 [Abstract] [Full Text] [Related]